ArticleInternational journal of retina and vitreous2025
Prevalence of diabetic macular edema among type II diabetic patients in tele-screening program using OCT and fundus photos in a tertiary hospital, Riyadh, Saudi Arabia.
Article in International journal of retina and vitreous, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo provide local data on the prevalence and risk factors of diabetic macular edema in the Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
methodA cross-sectional cohort study was conducted to screen the prevalence of diabetic macular edema among diabetic patients, with 906 patients randomly selected between May 2023 and September 2023 in a tele-screening program using OCT and fundus photos at the Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
resultsIn a sample of 906 diabetic patients who participated in a tele-screening program, 38 cases of diabetic macular edema (DME) were diagnosed, resulting in a prevalence of 4.19%. Males and females each composed 50% of the sample. The average age was 61.39 years (SD = 10.114), and 31.6% had diabetes for over 15 years. Most patients had comorbidities, including hypertension (86.8%) and dyslipidemia (89.5%). Diabetic complications were common: neuropathy was present in 23.6%, and nephropathy was present in 21%. Among the 48 eyes assessed, the mean central macular thickness was 315 ± 69 μm. The distribution of diabetic retinopathy severity in 48 eyes included 17 (35%) no retinopathy, 8 (17%) mild NPDR, 15 (31%) moderate NPDR, 7 (15%) severe NPDR, and 1 (2%) PDR. Center-involved DME was found in 45.8% of the eyes, whereas non-center-involved DME was observed in 54.2% of the eyes.
conclusionThis study in Riyadh, Saudi Arabia, revealed a 4.19% prevalence of diabetic macular edema (DME), emphasizing the importance of regular screening, especially for patients with longstanding diabetes, hypertension, and dyslipidemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.